Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP804322.RAHSeLexRNdja3A2jkncvCP-3QHrE_rcw_XSZzgyfO-F8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP804322.RAHSeLexRNdja3A2jkncvCP-3QHrE_rcw_XSZzgyfO-F8130_assertion type Assertion NP804322.RAHSeLexRNdja3A2jkncvCP-3QHrE_rcw_XSZzgyfO-F8130_head.
- NP804322.RAHSeLexRNdja3A2jkncvCP-3QHrE_rcw_XSZzgyfO-F8130_assertion description "[For three polymorphisms: CYP1A1*2A, CYP1A1*2B, and TNF -308 there was a pattern consistent with interaction between genotype and TDI exposure status for the majority of symptoms investigated, although it did reach statistical significance only for some symptoms: among TDI-exposed workers, the CYP1A1 variant carriers had increased risk (CYP1A1*2A and eye symptoms: variant carriers OR 2.0 95% CI 0.68-6.1, p-value for interaction 0.048; CYP1A1*2B and wheeze: IV carriers OR = 12, 1.4-110, p-value for interaction 0.057).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804322.RAHSeLexRNdja3A2jkncvCP-3QHrE_rcw_XSZzgyfO-F8130_provenance.
- NP804322.RAHSeLexRNdja3A2jkncvCP-3QHrE_rcw_XSZzgyfO-F8130_assertion evidence source_evidence_literature NP804322.RAHSeLexRNdja3A2jkncvCP-3QHrE_rcw_XSZzgyfO-F8130_provenance.
- NP804322.RAHSeLexRNdja3A2jkncvCP-3QHrE_rcw_XSZzgyfO-F8130_assertion SIO_000772 18447907 NP804322.RAHSeLexRNdja3A2jkncvCP-3QHrE_rcw_XSZzgyfO-F8130_provenance.
- NP804322.RAHSeLexRNdja3A2jkncvCP-3QHrE_rcw_XSZzgyfO-F8130_assertion wasDerivedFrom befree-20140225 NP804322.RAHSeLexRNdja3A2jkncvCP-3QHrE_rcw_XSZzgyfO-F8130_provenance.
- NP804322.RAHSeLexRNdja3A2jkncvCP-3QHrE_rcw_XSZzgyfO-F8130_assertion wasGeneratedBy ECO_0000203 NP804322.RAHSeLexRNdja3A2jkncvCP-3QHrE_rcw_XSZzgyfO-F8130_provenance.